Obtaining an accurate diagnosis is a crucial first step in kidney cancer care, according to Dr. Shuanzeng “Sam” Wei of Fox ...

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple ...

The company says a single node is capable of processing approximately 22,000 genomes annually, triple the amount of earlier releases.

The promise of messenger RNA (mRNA) has moved far beyond its pandemic-era spotlight. In oncology, mRNA has emerged as a ...

Johnson & Johnson Vietnam has partnered with Ho Chi Minh City Oncology Hospital to improve treatment for lung and prostate cancers through the first memorandum of understanding (MoU) signed between ...

Lenovo today shared updates on the 4th generation of its Genomics Optimization and Scalability Tool - GOAST v4.0. Since its ...

The global prostate cancer diagnostics market is expected to grow at a CAGR of ~12% during the forecast period. Rising ...

Incyte INCY announced that the FDA has approved the label expansion of Opzelura (ruxolitinib) cream 1.5%. Opzelura, a topical ...

Johnson & Johnson announced that an investigational immune-based induction regimen with TECVAYLI and DARZALEX FASPRO demonstrated meaningful ...

Scientists from the University of Sheffield have uncovered how to potentially control harmful insect populations by studying a "selfish gene" that ...

New research is shining a light on one of genetics’ enduring puzzles - how the workings of the so-called “selfish gene” could be harnessed to control harmful insect populations.

This phenomenon is not unique to Bangladesh but is typical of most post-colonial, weak-institutional and resource-scarce ...